BHVN - Biohaven Ltd.

QQQ $ 454.82 $ -0.84 (-0.19 %)

DIA $ 398.57 $ 6.05 (1.59 %)

SPY $ 530.36 $ 4.76 (0.91 %)

TLT $ 91.26 $ 0.61 (0.68 %)

GLD $ 225.37 $ -1.27 (-0.59 %)

Previous Close

$ 35.1

Open

$ 36.08

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 34.64 - $ 37.00

52 Week Range

$ 16.45 - $ 62.21

Volume

1,399,398

Average Volume

Market Cap

2.39B

Beta (5Y Monthly)

$ 1.84

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-09-2024	03-31-2024	10-Q
2	02-29-2024	12-31-2023	10-K
3	11-14-2023	09-30-2023	10-Q
4	07-31-2023	06-30-2023	10-Q
5	05-12-2023	03-31-2023	10-Q
6	03-23-2023	12-31-2022	10-K
7	11-09-2022	09-30-2022	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Reiterates Buy on Bioh...
05/30/2024 18:47:40

HC Wainwright & Co. analyst Douglas Tsao reiterates Biohaven (NYSE:BHVN) with a Buy and maintains $59 price target.

Cantor Fitzgerald Reiterates Overweight on...
05/30/2024 15:39:13

Cantor Fitzgerald analyst Charles Duncan reiterates Biohaven (NYSE:BHVN) with a Overweight.

HP Posts Upbeat Earnings, Joins Foot Locke...
05/30/2024 14:45:25

biohaven-stock-stumbles-as-protein-degrading-drug-falls-short-of-expectations-in-early-stage-study

Biohaven Stock Stumbles As Protein-Degradi...
05/29/2024 18:47:15

Biohaven shares drop as interim data from the Phase 1 study of BHV-1300 fell short of investor expectations.

12-health-care-stocks-moving-in-wednesdays-intraday-session

12 Health Care Stocks Moving In Wednesday'...
05/29/2024 16:31:13

whats-going-on-with-biohaven-stock-wednesday

What's Going On With Biohaven Stock Wednes...
05/29/2024 16:03:45

The company announced it dosed a patient with a new possible treatment for certain cancers, showcased positive data from two di...

Biohaven Highlights Development And Regula...
05/29/2024 12:33:44

Reports new interim data from the ongoing Phase 1 study of BHV-1300, Biohaven's lead investigational drug from its Molecula...

Biohaven Announces First Patient Dosed in ...
05/29/2024 12:27:55

12-health-care-stocks-moving-in-wednesdays-pre-market-session

12 Health Care Stocks Moving In Wednesday'...
05/29/2024 12:06:44

this-biotech-stock-is-poised-for-80-upside-with-breakthrough-in-obesity-drug-market-says-jpmorgan

This Biotech Stock Is Poised For 80% Upsid...
05/22/2024 02:41:37

The Structure Therapeutics stock has been identified as a potential winner in the obesity drug market. JPMorgan has given the s...

sony-group-posts-upbeat-earnings-joins-gamestop-paysafe-and-other-big-stocks-moving-higher-on-tuesday

Sony Group Posts Upbeat Earnings, Joins Ga...
05/14/2024 15:01:34

crocs-to-rally-around-19-here-are-10-top-analyst-forecasts-for-monday

Crocs To Rally Around 19%? Here Are 10 Top...
05/13/2024 12:31:26

HC Wainwright & Co. Maintains Buy on Bioha...
05/13/2024 11:52:02

HC Wainwright & Co. analyst Douglas Tsao maintains Biohaven (NYSE:BHVN) with a Buy and lowers the price target from $63 ...

Biohaven On Thursday Reported Q1 2024 Adj....
05/10/2024 14:22:16

around-1m-bet-on-biohaven-check-out-these-4-stocks-insiders-are-buying

Around $1M Bet On Biohaven? Check Out Thes...
04/26/2024 11:36:41

UBS Maintains Buy on Biohaven, Raises Pric...
04/23/2024 15:40:55

UBS analyst Ashwani Verma maintains Biohaven (NYSE:BHVN) with a Buy and raises the price target from $59 to $60.

Cantor Fitzgerald Reiterates Overweight on...
04/18/2024 13:51:23

Cantor Fitzgerald analyst Charles Duncan reiterates Biohaven (NYSE:BHVN) with a Overweight.

Biohaven Reports Pricing Of Public Offerin...
04/18/2024 10:02:11

The gross proceeds from the offering are expected to be approximately $230 million before deducting underwriting discounts and ...

Biohaven Announces $200M Public Offering O...
04/17/2024 20:15:35

Biohaven Ltd. (NYSE:BHVN), a biopharmaceutical company focused on the discovery, development and commercialization of life-chan...

why-ultragenyx-pharmaceutical-shares-are-trading-lower-by-around-9-here-are-other-stocks-moving-in-mondays-mid-day-session

Why Ultragenyx Pharmaceutical Shares Are T...
04/15/2024 18:11:35

Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new d...